[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"hemorrhage-brain\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:hemorrhage-brain":28},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,2,0,[8,49],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":17,"enrollmentInfo":18,"targetDuration":4,"studyType":21,"phases":22,"briefSummary":24,"conditions":25,"keywords":30,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":37,"lastUpdatePostDateStruct":38,"startDateStruct":41,"completionDateStruct":43,"leadSponsor":45,"locationsCount":48},"100538128","personalized-transcranial-direct-current-stimulation-in-stroke-recovery-100538128",false,"NCT06286800","Personalized Transcranial Direct Current Stimulation in Stroke Recovery","Inclusion Criteria:\n\n* Symptomatic ischemic or hemorrhagic stroke verified by computerized axial tomography or magnetic resonance imaging resulting in hemiparesis (MRC 1-4).\n* Age more than 18, Male or Female, All racial and ethnic groups\n* Entry into the study \\>3 months post onset\n* Modified Ashworth Scale Score \\\u003C3 in the involved upper extremity\n* Passive range of motion within functional ranges at the shoulder, elbow, wrist and hand\n* Able to follow 2 step commands\n\nExclusion Criteria:\n\n* Patients with history of severe alcohol or drug abuse, psychiatric illnesses like severe depression, poor motivational capacity, or severe language disturbances, particularly of receptive nature or with serious cognitive deficits (defined as unable to follow study instructions).\n* Patients with bilateral paresis, or weakness or sensory damage due to peripheral causes (e.g. peripheral nerve injury, muscle or orthopedic injury etc.)\n* Patients with severe uncontrolled medical problems (e.g. cardiovascular disease, severe rheumatoid arthritis, active joint deformity of arthritic origin, active cancer or renal disease, any kind of end-stage pulmonary or cardiovascular disease, or a deteriorated condition due to age,epilepsy or others).\n* Patients with unstable cardiac arrhythmia.\n* Pregnancy\n* Patients with metallic implants in the head, patients with pacemakers, patients with craniotomies, including burr holes who cannot be safely stimulated\n* Patients with seizures\n* Non-English speaking individuals will only be eligible if they can provide the appropriate translator for all the sessions of the study as no funding is available to pay for such services.","ALL","18 Years","80 Years",{"count":19,"type":20},80,"ESTIMATED","INTERVENTIONAL",[23],"NA","The central objective of this application is to explore the neural substrate of personalized tDCS (ptDCS) and to determine whether the paradigm for each stroke patient can predict the amount of sustained clinical improvement through increased connectivity as measured by a biomarker of plasticity.",[26,27,28,29],"Stroke","Chronic Stroke","Hemorrhage Brain","Ischemic Stroke",[31,32,33,34,35],"tdcs","noninvasive cortical stimulation","functional connectivity","hemiparesis","arm weakness","RECRUITING","2026-02-27",{"date":39,"type":40},"2026-03-02","ACTUAL",{"date":42,"type":40},"2024-12-18",{"date":44,"type":20},"2027-09-14",{"name":46,"class":47},"The Methodist Hospital Research Institute","OTHER",1,{"id":50,"slug":51,"hasResults":11,"nctId":52,"briefTitle":53,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":11,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":56,"targetDuration":4,"studyType":58,"phases":4,"briefSummary":59,"conditions":60,"keywords":62,"overallStatus":36,"whyStopped":4,"lastUpdateSubmitDate":65,"lastUpdatePostDateStruct":66,"startDateStruct":68,"completionDateStruct":70,"leadSponsor":72,"locationsCount":48},"100617894","microfabricated-microcatheter-advantages-in-middle-meningeal-artery-embolization-an-early-experience-at-a-single-center-100617894","NCT07324551","Microfabricated Microcatheter Advantages in Middle Meningeal Artery Embolization: an Early Experience at a Single Center","SCIENTIA","Inclusion Criteria:\n\n* Age ≥ 18 years old\n* Patient or legally authorized representative (LAR) signs an informed consent form\n* Confirmed diagnosis of subacute or chronic subdural hematoma, defined as 50% or more chronic blood\n* Pre-morbid Modified Rankin Score of ≤ 3\n\nExclusion Criteria:\n\n* Age \\\u003C 18 years old\n* Potentially dangerous anatomic variations leading to increased procedural risk or unsafe access for MMA embolization\n* Unmanaged, uncontrolled bleeding disorders\u002Fblood diathesis\n* Presumed septic embolus, or suspicion of microbial superinfection\n* Contraindication to angiography\n* CT or MRI evidence of intra-cranial tumor or mass lesion",{"count":57,"type":20},100,"OBSERVATIONAL","The purpose of this study is to evaluate the function of matched pair Aristotle 14 Guidewire and Plato Microcatheter in MMA embolization treatment for chronic subdural hematoma compared to surgeon's preference",[61,28],"Chronic Subdural Hematoma",[63,64,61],"MMA Embolization","cSDH","2025-12-23",{"date":67,"type":40},"2026-01-07",{"date":69,"type":40},"2025-11-03",{"date":71,"type":20},"2029-07-01",{"name":73,"class":47},"Ohio State University"]